Puration announces strategy to become cannabis market leader
Puration plans to displace pharmaceutical market leader, GW Pharmaceuticals, as part of strategy to grow US cannabis market
List view / Grid view
News
Pall Corporation Introduces Proprietary Bioreactor Control System
Pall Corporation, a leader in filtration, separation and purification, is pleased to introduce the mPath™ bioreactor control system to the biopharmaceutical market...
Lonza Pharma&Biotech Launches Ibex™ Solutions – An Innovative New Concept in Biological Manufacturing and Development
Lonza’s commitment to constant innovation and adding value to its customers and partners is today demonstrated by the launch of Ibex™ Solutions – a unique addition to its current offering...
Is extended-release guanfacine effective in children with chronic tic disorders?
A new study has assessed the safety, tolerability, and effectiveness of extended-release guanfacine in children 6-17 years of age who have chronic tic disorders including Tourette's disorder.
New Workflow Is First End-to-End Solution For Extrusion-Based Drug Implant Production
Thermo Scientific Pharma mini implant line is an automated, integrated system designed for continuous production of drug implants...
Multi-million funding for cryo-EM to boost structural biology revolution
US science minister announce new multi-million-pound commitment to boost the burgeoning field of cryo-electron microscopy (cryo-EM) in the UK.
Global research programme to tackle humanitarian crises
£225 million has been invested across 37 interdisciplinary projects to address challenges in fields such as health, humanitarian crises...
C difficile infections market to hit $1.7bn by 2026
GlobalData latest report states that the major drivers of this growth include the projected launch of prophylactic options for the prevention of Clostridium difficile infections...
Patients at risk as UK plans to leave Euratom
The UK's proposed withdrawal from Euratom may threaten the supply of essential medical isotopes, putting cancer patients at risk...
Uncovering the cause of immunotherapy resistance in tumours
Scientists have uncovered a key factor in the development of immunotherapy resistance in the case of cutaneous melanoma. This could potentially lead to future improvements in cancer therapy.
Double network hydrogels make drug-releasing systems safer
Double network hydrogel composed of two interwoven polymer nets to improve the safety of drug-delivery systems that reside within the stomach...
US ophthalmic drugs market set to pass $34bn by 2025
Major market players across the US are upping investments in research to innovate on treatment methods and improve ophthalmic drugs action...
Influenza virus mutations prevented during vaccine production
Duke researchers used a bivalent virus from chicken cells that packaged twice as much protein as a monovalent virus, and vaccinated mice with either the bivalent or monovalent vaccine
Growth in next-generation sequencing informatics market fuelled by big data
Report predicts strong demand from biopharma will encourage NGS informatics providers to deliver customised solutions
Gilead’s fixed-dose (BIC/FTC/TAF) combination for HIV show high tolerability
Phase 3 trials of Gilead’s fixed-dose (BIC/FTC/TAF) combination for HIV show high tolerability and low resistance
